AIM
ZBH icon

Axiom Investment Management’s Zimmer Biomet ZBH Stock Holding History

Axiom Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,823
Closed -$664K – 436
2019
Q2 		$664K Sell
5,823
-6
-0.1% -$703 0.12% 181
2019
Q1 		$717K Buy
5,829
+481
+9% +$54.7K 0.14% 166
2018
Q4 		$539K Buy
+5,348
New +$601K 0.11% 177

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Axiom Investment Management's ZBH Position: Q3 2019 in Review

Axiom Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2019, closing a stake of 5,823 shares — an estimated $664K sold.

Axiom Investment Management first reported a position in ZBH in Q4 2018 and held it in 3 quarters. The position peaked at $717K in Q1 2019. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

  • Axiom Investment Management reported no remaining Zimmer Biomet position as of Q3 2019 after selling out during the quarter.
  • Axiom Investment Management sold 5,823 Zimmer Biomet shares in Q3 2019, an estimated $664K.
  • Axiom Investment Management first reported a position in Zimmer Biomet in Q4 2018 and held it in 3 quarters.
  • Axiom Investment Management's Zimmer Biomet position peaked at $717K in Q1 2019.
  • 896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Axiom Investment Management's 13F filing for Q3 2019, filed 16 Mar 2021.